![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of EIF3D mRNA] | CTD | PMID:31150632 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:1551512 | 6480464 | Ethinyl Estradiol affects the expression of EIF3D mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1551512 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EIF3D mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:1551512 | 6480464 | Ethinyl Estradiol results in increased expression of EIF3D mRNA | CTD | PMID:17942748 | 17beta-estradiol | affects expression | ISO | RGD:1551512 | 6480464 | Estradiol affects the expression of EIF3D mRNA | CTD | PMID:15598610 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | RGD:1551512 | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1551512 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EIF3D mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EIF3D mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1551512 | 6480464 | Tetrachlorodibenzodioxin affects the expression of EIF3D mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1551512 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EIF3D mRNA | CTD | PMID:17942748 | 2,4,6-tribromophenol | decreases expression | ISO | RGD:1352969 | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 4-dinitrotoluene affects the expression of EIF3D mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 6-dinitrotoluene affects the expression of EIF3D mRNA | CTD | PMID:21346803 | 3H-1,2-dithiole-3-thione | increases expression | ISO | RGD:1551512 | 6480464 | 1, 2-dithiol-3-thione results in increased expression of EIF3D mRNA | CTD | PMID:15375163 | all-trans-retinoic acid | decreases expression | ISO | RGD:1352969 | 6480464 | Tretinoin results in decreased expression of EIF3D mRNA | CTD | PMID:33167477 | antirheumatic drug | decreases expression | ISO | RGD:1352969 | 6480464 | Antirheumatic Agents results in decreased expression of EIF3D mRNA | CTD | PMID:24449571 | atrazine | increases expression | ISO | RGD:1352969 | 6480464 | Atrazine results in increased expression of EIF3D mRNA | CTD | PMID:22378314 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of EIF3D mRNA | CTD | PMID:25181051, PMID:34947998 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of EIF3D mRNA | CTD | PMID:33296240 | bisphenol A | affects expression | ISO | RGD:1352969 | 6480464 | bisphenol A affects the expression of EIF3D mRNA | CTD | PMID:30903817 | butan-1-ol | multiple interactions | ISO | RGD:1352969 | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EIF3D mRNA | CTD | PMID:29432896 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of EIF3D mRNA | CTD | PMID:21297351 | carbon nanotube | multiple interactions | ISO | RGD:1551512 | 6480464 | [Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of EIF3D protein | CTD | PMID:34864091 | chloropicrin | increases expression | ISO | RGD:1352969 | 6480464 | chloropicrin results in increased expression of EIF3D mRNA | CTD | PMID:26352163 | chromium(6+) | affects expression | ISO | RGD:1551512 | 6480464 | chromium hexavalent ion affects the expression of EIF3D mRNA | CTD | PMID:28472532 | chrysene | increases expression | ISO | RGD:1551512 | 6480464 | chrysene results in increased expression of EIF3D mRNA | CTD | PMID:26377693 | cyclosporin A | increases expression | ISO | RGD:1352969 | 6480464 | Cyclosporine results in increased expression of EIF3D mRNA | CTD | PMID:20106945, PMID:25562108 | dibutyl phthalate | decreases expression | ISO | RGD:1551512 | 6480464 | Dibutyl Phthalate results in decreased expression of EIF3D mRNA | CTD | PMID:17361019 | dibutyl phthalate | multiple interactions | ISO | RGD:1551512 | 6480464 | [Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of EIF3D protein | CTD | PMID:34864091 | doxorubicin | increases expression | ISO | RGD:1352969 | 6480464 | Doxorubicin results in increased expression of EIF3D mRNA | CTD | PMID:29803840 | enzyme inhibitor | multiple interactions | ISO | RGD:1352969 | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EIF3D protein | CTD | PMID:23301498 | fenthion | decreases expression | ISO | RGD:1551512 | 6480464 | Fenthion results in decreased expression of EIF3D mRNA | CTD | PMID:34813904 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of EIF3D mRNA | CTD | PMID:24136188 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of EIF3D mRNA | CTD | PMID:22061828, PMID:33387578 | ivermectin | decreases expression | ISO | RGD:1352969 | 6480464 | Ivermectin results in decreased expression of EIF3D protein | CTD | PMID:32959892 | methidathion | decreases expression | ISO | RGD:1551512 | 6480464 | methidathion results in decreased expression of EIF3D mRNA | CTD | PMID:34813904 | paracetamol | affects expression | ISO | RGD:1551512 | 6480464 | Acetaminophen affects the expression of EIF3D mRNA | CTD | PMID:17562736 | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of EIF3D mRNA | CTD | PMID:32680482 | perfluorohexanesulfonic acid | decreases expression | ISO | RGD:1352969 | 6480464 | perfluorohexanesulfonic acid results in decreased expression of EIF3D mRNA | CTD | PMID:25812627 | perfluorononanoic acid | decreases expression | ISO | RGD:1352969 | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of EIF3D mRNA | CTD | PMID:25812627 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:1352969 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of EIF3D mRNA | CTD | PMID:25812627 | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of EIF3D mRNA | CTD | PMID:19162173 | perfluorooctanoic acid | decreases expression | ISO | RGD:1352969 | 6480464 | perfluorooctanoic acid results in decreased expression of EIF3D mRNA | CTD | PMID:25812627 | picoxystrobin | increases expression | ISO | RGD:1352969 | 6480464 | picoxystrobin results in increased expression of EIF3D mRNA | CTD | PMID:33512557 | rotenone | increases expression | ISO | RGD:1352969 | 6480464 | Rotenone results in increased expression of EIF3D mRNA | CTD | PMID:33512557 | sodium arsenite | decreases expression | ISO | RGD:1352969 | 6480464 | sodium arsenite results in decreased expression of EIF3D protein | CTD | PMID:30528433 | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of EIF3D mRNA | CTD | PMID:25993096 | sodium fluoride | decreases expression | ISO | RGD:1551512 | 6480464 | Sodium Fluoride results in decreased expression of EIF3D protein | CTD | PMID:28918527 | sunitinib | increases expression | ISO | RGD:1352969 | 6480464 | Sunitinib results in increased expression of EIF3D mRNA | CTD | PMID:31533062 | T-2 toxin | increases expression | EXP | | 6480464 | T-2 Toxin results in increased expression of EIF3D mRNA | CTD | PMID:26141394 | tamoxifen | affects expression | ISO | RGD:1551512 | 6480464 | Tamoxifen affects the expression of EIF3D mRNA | CTD | PMID:17555576 | tetrachloromethane | increases expression | ISO | RGD:1551512 | 6480464 | Carbon Tetrachloride results in increased expression of EIF3D mRNA | CTD | PMID:27339419, PMID:31919559 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of EIF3D mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of EIF3D mRNA] | CTD | PMID:31150632 | valproic acid | decreases expression | ISO | RGD:1551512 | 6480464 | Valproic Acid results in decreased expression of EIF3D mRNA | CTD | PMID:21427059 | valproic acid | affects expression | ISO | RGD:1551512 | 6480464 | Valproic Acid affects the expression of EIF3D mRNA | CTD | PMID:17292431 | valproic acid | decreases expression | ISO | RGD:1352969 | 6480464 | Valproic Acid results in decreased expression of EIF3D mRNA | CTD | PMID:19101580, PMID:23179753 | valproic acid | affects expression | ISO | RGD:1352969 | 6480464 | Valproic Acid affects the expression of EIF3D mRNA | CTD | PMID:25979313 | |